Altimmune, Inc. (ALT)

4.015 -0.06 (-1.59%) USD  |  NASDAQ  |  Jan 09, 14:22
More

Altimmune Price Target Upside (Daily)

Price Target Upside (Daily) Chart

View Price Target Upside (Daily) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Upside (Daily) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Upside (Daily) Range, Past 5 Years

View Price Target Upside (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Upside (Daily) Benchmarks

View Price Target Upside (Daily) Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
Amgen, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade